Literature DB >> 6365177

The mechanism of liposome accumulation in infarction.

T N Palmer, V J Caride, M A Caldecourt, J Twickler, V Abdullah.   

Abstract

This paper explores the mechanism(s) whereby liposomes accumulate in chronically ischaemic myocardium and intestine. Plasma prepared from venous blood obtained at sites of myocardial and intestinal infarction does not promote the lysis of positively and negatively charged liposomes in vitro. Albumin-bound lysophosphatidylcholine (greater than or equal to 2 mM) lyses positively and negatively charged liposomes in vitro at similar rates. [99mTc]Diethylenetriamine pentaacetic acid (DTPA) entrapped in positively charged liposomes was accumulated in ischaemic rat caecum/colon 6 and 24 h after mesenteric ligation. Presumably allied to the accumulation of liposomal components, necrotic caecum/colon showed marked Ca2+ accumulation and phospholipid depletion. It is postulated that Ca2+ and Ca2+-activated membrane phospholipases may be implicated in the mechanism of liposome accumulation in chronic ischaemia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6365177     DOI: 10.1016/0304-4165(84)90258-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

Review 1.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

2.  ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction.

Authors:  Daya D Verma; William C Hartner; Tatayana S Levchenko; Eugene A Bernstein; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2005-11-05       Impact factor: 4.200

3.  Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity.

Authors:  Erez Koren; Anjali Apte; Ankur Jani; Vladimir P Torchilin
Journal:  J Control Release       Date:  2011-12-13       Impact factor: 9.776

4.  Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids.

Authors:  Junping Wang; Dimitry Mongayt; Vladimir P Torchilin
Journal:  J Drug Target       Date:  2005-01       Impact factor: 5.121

5.  Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice.

Authors:  Anatoly N Lukyanov; Zhonggao Gao; Laureen Mazzola; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

6.  A polymeric nanoparticle consisting of mPEG-PLA-Toco and PLMA-COONa as a drug carrier: improvements in cellular uptake and biodistribution.

Authors:  Yilwoong Yi; Jae Hong Kim; Hye-Won Kang; Hun Seung Oh; Sung Wan Kim; Min Hyo Seo
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

7.  Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.

Authors:  Swati Biswas; Namita S Dodwadkar; Rupa R Sawant; Vladimir P Torchilin
Journal:  Bioconjug Chem       Date:  2011-09-12       Impact factor: 4.774

8.  pH (low) insertion peptide (pHLIP) targets ischemic myocardium.

Authors:  Eugene A Sosunov; Evgeny P Anyukhovsky; Alexander A Sosunov; Anna Moshnikova; Dayanjali Wijesinghe; Donald M Engelman; Yana K Reshetnyak; Oleg A Andreev
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

9.  Protective effect of coenzyme Q10-loaded liposomes on the myocardium in rabbits with an acute experimental myocardial infarction.

Authors:  Daya D Verma; William C Hartner; Vineet Thakkar; Tatyana S Levchenko; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

Review 10.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

Authors:  Vladimir Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.